“To achieve two INDs for our programs (OV and B Cell) concurrently is an outstanding result for the team,” says MD.
Imugene secures FDA approval for two clinical trials of promising oncology drug candidates
SWiM PAY combines world leading payments, FX, KYC and cross border payments